Versor Investments LP Makes New $1.93 Million Investment in Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Versor Investments LP acquired a new position in Sabra Healthcare REIT, Inc. with 110,700 shares purchased, valued at approximately $1,934,000.
• Director Michael J. Foster sold 11,000 shares of SBRA for a total of $200,420, resulting in a 14.53% decrease in their ownership.
• The company has declared a quarterly dividend of $0.30 per share, with a dividend yield of 6.5%.

Versor Investments LP purchased a new position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 110,700 shares of the real estate investment trust's stock, valued at approximately $1,934,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. UMB Bank n.a. increased its stake in Sabra Healthcare REIT by 379.6% during the 1st quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock valued at $36,000 after purchasing an additional 1,621 shares in the last quarter. Assetmark Inc. boosted its holdings in shares of Sabra Healthcare REIT by 37.8% in the first quarter. Assetmark Inc. now owns 3,607 shares of the real estate investment trust's stock worth $63,000 after buying an additional 989 shares during the last quarter. Fifth Third Bancorp boosted its holdings in shares of Sabra Healthcare REIT by 110.3% in the first quarter. Fifth Third Bancorp now owns 3,835 shares of the real estate investment trust's stock worth $67,000 after buying an additional 2,011 shares during the last quarter. GF Fund Management CO. LTD. bought a new position in shares of Sabra Healthcare REIT in the fourth quarter worth approximately $74,000. Finally, Harbor Capital Advisors Inc. boosted its position in shares of Sabra Healthcare REIT by 17.2% in the first quarter. Harbor Capital Advisors Inc. now owns 4,377 shares of the real estate investment trust's stock worth $76,000 after purchasing an additional 642 shares during the period. 99.40% of the stock is currently owned by institutional investors.

Sabra Healthcare REIT Stock Down 0.2%

Shares of Sabra Healthcare REIT stock traded down $0.0450 on Friday, reaching $19.5750. The stock had a trading volume of 1,847,873 shares, compared to its average volume of 2,451,325. The company has a 50 day moving average price of $18.42 and a 200 day moving average price of $17.67. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. Sabra Healthcare REIT, Inc. has a 1 year low of $15.60 and a 1 year high of $20.03. The stock has a market capitalization of $4.69 billion, a P/E ratio of 25.76, a P/E/G ratio of 1.55 and a beta of 0.86.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.02. The company had revenue of $189.15 million during the quarter, compared to analysts' expectations of $185.64 million. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. Sabra Healthcare REIT's revenue for the quarter was up 7.4% on a year-over-year basis. During the same period last year, the business earned $0.36 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. As a group, equities research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Friday, August 15th will be paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 6.1%. The ex-dividend date is Friday, August 15th. Sabra Healthcare REIT's payout ratio is presently 157.89%.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. JMP Securities upped their target price on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research report on Wednesday, August 6th. Scotiabank upped their price target on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research note on Monday, June 23rd. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Sabra Healthcare REIT currently has a consensus rating of "Moderate Buy" and a consensus target price of $20.00.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.